FTC Sues PBMs Over Insulin Prices, Citing a ‘Perverse System’
The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said Friday in announcing an administrative complaint against firms that are divisions of CVS Health,
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of “engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs,
FTC sues three largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while
FTC sues big 3 PBMs for ‘artificially inflated’ insulin prices caused by ‘perverse’ rebating
The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to pay more for insulin.
FTC Sues CVS Health, Cigna And United Health Group For Inflating Insulin Prices
The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's
Feds sue pharmacy gatekeepers over high insulin costs
The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug prices on behalf of insurers, claiming they are illegally maximizing profits by steering patients to high-cost insulin products.
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies.
American Pharmacists Association applauds FTC action on PBMs' alleged inflation of insulin drug prices
Hogue, PharmD, FAPhA, FNAP, FFIP, executive vice president and CEO of APhA, commended the Federal Trade Commission's (FTC) action today against alleged practices by large vertically integrated pharmacy benefit managers (PBMs) "for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs,
FTC Sues CVS, Cigna, UnitedHealth Over Insulin Costs
Bloomberg's Tyler Kendall breaks down the latest in the suit accusing the drug middlemen of engaging in illegal rebate programs that drove up the price of insulin. (Source: Bloomberg)
IJR1h
Biden-Harris FTC Accuses Major Healthcare Companies Of Artificially Inflating Drug Prices In New Lawsuit
The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...
Fierce Healthcare1d
FTC formally sues PBMs over insulin prices and warns manufacturers
“As the complaint explains, the PBMs have created and manage a system in which drug manufacturers compete for formulary ...
FTC Takes Legal Action Against Three Largest PBMs Over High Insulin Prices
Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
Modern Healthcare1d
FTC targets 3 biggest PBMs over insulin rebates
The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
East Idaho News3h
New Idaho law to regulate pharmacy benefit managers. Will it reduce prescription drug costs?
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of tamping down prescription drug costs. The new law targets pharmacy benefit ...